CRISPR-based diagnostics
- PMID: 34272525
- DOI: 10.1038/s41551-021-00760-7
CRISPR-based diagnostics
Abstract
The accurate and timely diagnosis of disease is a prerequisite for efficient therapeutic intervention and epidemiological surveillance. Diagnostics based on the detection of nucleic acids are among the most sensitive and specific, yet most such assays require costly equipment and trained personnel. Recent developments in diagnostic technologies, in particular those leveraging clustered regularly interspaced short palindromic repeats (CRISPR), aim to enable accurate testing at home, at the point of care and in the field. In this Review, we provide a rundown of the rapidly expanding toolbox for CRISPR-based diagnostics, in particular the various assays, preamplification strategies and readouts, and highlight their main applications in the sensing of a wide range of molecular targets relevant to human health.
© 2021. Springer Nature Limited.
References
-
- Neal, R. D. et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br. J. Cancer https://doi.org/10.1038/bjc.2015.48 (2015).
-
- Yang, S. & Rothman, R. E. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(04)01044-8 (2004).
-
- Weissleder, R., Lee, H., Ko, J. & Pittet, M. J. COVID-19 diagnostics in context. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.abc1931 (2020).
-
- Burki, T. K. Testing for COVID-19. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(20)30247-2 (2020).
-
- Mahony, J. B. et al. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. J. Clin. Microbiol. https://doi.org/10.1128/JCM.00556-09 (2009).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical